Cancer Research Institute (CRI) shared a post on LinkedIn:
“Research into screening and vaccination has transformed cervical cancer prevention, but has also left a critical gap in effective therapies for patients who require intensive treatment, and continue to face poor outcomes.
Former CRI CLIP Investigator Dr. W. Martin Kast at Keck Medicine of USC aims to address this gap. Dr. Kast’s work focuses on how the immune system responds to standard cervical cancer treatment, and how immunotherapy can strengthen those responses- highlighting new ways the immune system may be harnessed to create longer-lasting protection against cervical cancer.
During Cervical Cancer Awareness Month, discover how today’s discoveries are shaping tomorrow’s treatments- offering renewed hope for patients with cervical cancer.”
More posts featuring CRI on OncoDaily.